** Analysts at Morningstar forecast operating profit margin
to better pre-pandemic levels for Australia's Ansell ANN.AX ,
even as customer destocking in surgical & life science
businesses expected to persist until 2H 2024
** Broker forecasts EBIT margin for Aussie glove maker to
expand to 15% by FY28 from 13% in FY23
** The broker maintains price target on stock at A$30.00 per
share, sets "Medium" uncertainty rating
** Says FY24 EPS forecast of $1.01 remains within ANN's
reiterated guidance of $0.92 to $1.12
** ANN's productivity program still guided to deliver at
least $45 mln in annualized cost savings by FY26 - analysts at
Morningstar
** Stock down 23.9% YTD, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com;))